However, FGL2 mRNA relative expression did not differ between stage A and B HCC tissues as well as between the corresponding adjacent non-tumor tissues obtained from the same stage A and B HCC patients (P > 0.05) (Fig. 2e). Here, FGL2 is linked to hepatocellular carcinoma.